Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials KIDNEY INTERNATIONAL Wyatt, C. M., Shineski, M., Chertow, G. M., Bangalore, S. 2016; 89 (6): 1178–79

Abstract

Despite the high cardiovascular risk associated with chronic kidney disease, a recent systematic review confirmed that patients with kidney disease remain underrepresented in cardiovascular trials. Two ongoing trials are assessing the risk:benefit of aggressive evaluation and intervention for ischemic heart disease in patients with advanced chronic kidney disease.

View details for DOI 10.1016/j.kint.2016.03.012

View details for Web of Science ID 000375693100002

View details for PubMedID 27181770